HeartBeam (BEAT) Long-Term Debt Issuances (2020 - 2021)
HeartBeam (BEAT) reported Long-Term Debt Issuances of $155000.0 for Q4 2021, up 1292.31% year-over-year from $11132.6 in Q4 2020, and down 77.7% on a QoQ basis from $695000.0 in Q3 2021.
HeartBeam (BEAT) has 2 years of Long-Term Debt Issuances data on file, last reported at $155000.0 in Q4 2021.
- Quarterly Long-Term Debt Issuances rose 1292.31% year-over-year to $155000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $155000.0 (down 89.98% YoY) and the FY2021 annual result came in at $1.7 million, up 177.96% from the prior year.
- Long-Term Debt Issuances slipped to $155000.0 in Q4 2021 per BEAT's latest filing, from $695000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $695000.0 in Q3 2021 and bottomed at -$13000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 19.80 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | HeartBeam | 5.16 Mn | 5.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 155,000.00 |
| Dec 31, 2021 | 155,000.00 |
| Sep 30, 2021 | 695,000.00 |
| Sep 30, 2021 | 695,000.00 |
| Jun 30, 2021 | 650,000.00 |
| Jun 30, 2021 | 650,000.00 |
| Mar 31, 2021 | 215,000.00 |
| Mar 31, 2021 | 215,000.00 |
| Dec 31, 2020 | -13,000.00 |
| Dec 31, 2020 | -13,000.00 |